Butanilicaine
Names | |
---|---|
IUPAC name N2-Butyl-N1-(2-chloro-6-methylphenyl)glycinamide | |
Systematic IUPAC name 2-(Butylamino)-N-(2-chloro-6-methylphenyl)acetamide | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEBI |
|
ChEMBL |
|
ChemSpider |
|
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C13H19ClN2O |
Molar mass | 254.75576 |
Pharmacology | |
N01BB05 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references |
Chemical compound
Butanilicaine is a local anesthetic. It is also known by the name Hostacaine.
Synthesis
The amide formation between 2-Chloro-6-Methylaniline [87-63-8] (1) and Chloroacetyl chloride (2) gives 2-Chloro-n-(2-chloro-6-methylphenyl)acetamide [6307-67-1] (3). Alkylation with N-Butylamine (4) completed the synthesis of Butanilicaine (5).
References
- ^ Haussler A, Ther L. [Chemical detection of hostacain]. Arzneimittelforschung. 1953;3(12):609-11.
- ^ Epstein, Elias; Kaminsky, Daniel (1958). "N-(Substituted Aminoacyl)-chloroanilines". Journal of the American Chemical Society 80 (8): 1892–1895. doi:10.1021/ja01541a028.
- ^ GB 726080 (1955 to Polymer Corp.)
- ^ GB 759744 (1956 to Cilag)
- ^ GB 782971 1957 to Hoechst AG.
- ^ G. Ehrhart et al., U.S. patent 2,912,460 (1959 to Hoechst).
- v
- t
- e
Aminobenzoic | |
---|---|
Benzoic | |
ArCO2- (not para-amino or Ph) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e